SNES Stock Overview
Develops a technology for managing animal pest populations through fertility control. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 2/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
+ 2 more risks
SenesTech, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$2.26 |
| 52 Week High | US$23.40 |
| 52 Week Low | US$1.90 |
| Beta | 0.55 |
| 11 Month Change | -20.02% |
| 3 Month Change | -44.78% |
| 1 Year Change | -89.57% |
| 33 Year Change | -99.93% |
| 5 Year Change | -99.99% |
| Change since IPO | -100.00% |
Recent News & Updates
Shareholder Returns
| SNES | US Pharmaceuticals | US Market | |
|---|---|---|---|
| 7D | -10.0% | -3.8% | -1.0% |
| 1Y | -89.6% | 9.8% | 30.3% |
Return vs Industry: SNES underperformed the US Pharmaceuticals industry which returned 9.8% over the past year.
Return vs Market: SNES underperformed the US Market which returned 30.3% over the past year.
Price Volatility
| SNES volatility | |
|---|---|
| SNES Average Weekly Movement | 17.9% |
| Pharmaceuticals Industry Average Movement | 9.6% |
| Market Average Movement | 6.2% |
| 10% most volatile stocks in US Market | 15.7% |
| 10% least volatile stocks in US Market | 3.1% |
Stable Share Price: SNES's share price has been volatile over the past 3 months compared to the US market.
Volatility Over Time: SNES's weekly volatility has decreased from 24% to 18% over the past year, but is still higher than 75% of US stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2004 | 25 | Joel Fruendt | www.senestech.com |
SenesTech, Inc. develops a technology for managing animal pest populations through fertility control. It offers ContraPest, a liquid bait that limits reproduction of male and female rats. The company was incorporated in 2004 and is headquartered in Phoenix, Arizona.
SenesTech, Inc. Fundamentals Summary
| SNES fundamental statistics | |
|---|---|
| Market cap | US$2.34m |
| Earnings (TTM) | -US$6.66m |
| Revenue (TTM) | US$1.65m |
1.4x
P/S Ratio-0.4x
P/E RatioIs SNES overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| SNES income statement (TTM) | |
|---|---|
| Revenue | US$1.65m |
| Cost of Revenue | US$823.00k |
| Gross Profit | US$828.00k |
| Other Expenses | US$7.49m |
| Earnings | -US$6.66m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -6.45 |
| Gross Margin | 50.15% |
| Net Profit Margin | -403.51% |
| Debt/Equity Ratio | 6.1% |
How did SNES perform over the long term?
See historical performance and comparison